- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03515135
A Randomized Controlled Study of MEFP for Preschool Children With ADHD
March 16, 2020 updated by: Jinsong Zhang, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Metacognitive Executive Function Training for Preschool Children With ADHD - A Randomized Controlled Study
The goal of this study is to provide a new, early treatment approach for preschoolers with ADHD, which could facilitate the EF developing well to achieve better outcome.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
ADHD in preschoolers has become established as a valid psychiatric disorder with characterized core deficits of executive function (EF).
The EF impairments occurred in preschool period could persist to childhood, adolescent and adulthood, causing extensive and deep damage of individual's academic and career achievement, social function, and peer relationship.
Psychostimulants remain a controversial opinion for preschoolers and appear less efficacious and more common side effects.
It is very important to explore the effective nonpharmacological intervention targeting the EF deficits and appropriately tailored to young children.
Therefore, the investigators conduct this randomized and controlled study to find out the therapeutic efficacy of metacognitive Executive Function Training for Preschool Children with ADHD (MEFP), and follow the subjects to observe whether the therapeutic efficacy would persist.
In the mean time, the investigators also observe the factors which can influence the therapeutic efficacy.
The goal of this study is to provide a new, early treatment approach for preschoolers with ADHD, which could facilitate the EF developing well to achieve better outcome.
Study Type
Interventional
Enrollment (Actual)
96
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Shanghai, China, 200092
- Xinhua Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
4 years to 6 years (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- meet both the criteria of ADHD based on the interview by the DIPA and clinical diagnosis with DSM-5;
- full-scale IQ estimated by the Wechsler Primary and Preschool Scale of Intelligence (WPPSI) above 80;
- their parents volunteered to participate in this study.
Exclusion Criteria:
- child with severe mental disorder or physical disease that might interfere the assessment and intervention, such as Autistic Spectrum Disorder(ASD), schizophrenia, epilepsy, traumatic brain injury, etc.;
- receive medication intervention for their ADHD symptoms before study;
- parents with severe mental illness, such as schizophrenia, mood disorder (period of onset), etc..
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Intervention group
Subjects in this group will receive the "Metacognitive Executive Function Training (MEFP)" program in aiming to reduce ADHD symptoms and improve the executive function.
|
Training the executive funtions of preshcool ADHD children through tasks and games repeatly but with fun.
Giving the parents strategies to help the prechool ADHD childred coping the symptoms and develop EF in the reallife.
|
|
NO_INTERVENTION: Waiting group
Subjects in this group will not receive the MEFP program during the study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The executive function of preschool child of ADHD
Time Frame: through the intervention completion, an average of 8 weeks
|
The executive function of preschool children of ADHD assessed by neuropsychological evaluation tool NEPSY
|
through the intervention completion, an average of 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The executive function in real life of preschool child of ADHD
Time Frame: through the intervention completion, an average of 8 weeks
|
The executive function in real life of preschool children of ADHD assessed by BRIEF
|
through the intervention completion, an average of 8 weeks
|
|
The ADHD symptoms of child
Time Frame: through the intervention completion, an average of 8 weeks
|
The ADHD symptoms of child assessed by SNAP
|
through the intervention completion, an average of 8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lan Shuai, Ph.D, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
June 1, 2017
Primary Completion (ACTUAL)
December 30, 2018
Study Completion (ACTUAL)
December 30, 2018
Study Registration Dates
First Submitted
November 7, 2017
First Submitted That Met QC Criteria
April 21, 2018
First Posted (ACTUAL)
May 3, 2018
Study Record Updates
Last Update Posted (ACTUAL)
March 18, 2020
Last Update Submitted That Met QC Criteria
March 16, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- XH-17-003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.